Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Dec;93(6):414-20.
doi: 10.1111/j.1365-2613.2012.00841.x.

Bilobar colorectal liver metastases: a new model for preclinical studies

Affiliations

Bilobar colorectal liver metastases: a new model for preclinical studies

Léon Maggiori et al. Int J Exp Pathol. 2012 Dec.

Abstract

This study aimed to develop a new model of colorectal liver metastases (LM) in the rat. Both single macroscopic and multiple bilobar microscopic LM were investigated, as this closely resembled the human situation, before right hepatectomy was performed for 'single' right LM. The single macroscopic LM was elicited by direct injection of DHD/K12 colorectal cancer cells under the capsule of the median liver lobe in immunocompetent BDIX rats. The bilobar micrometastases were elicited by intraportal injection of DHD/K12 cells. A preliminary protocol was conducted to assess the dose of cells required to inject in to the portal vein, using 10(6) , 2 × 10(6) and 3 × 10(6) DHD/K12 cells (n = 15 rats). The resultant protocol for the experimental model used intraportal injection of 10(6) DHD/K12 cells and direct injections of 0.5 × 10(6) , 10(6) and 1.5 × 10(6) DHD/K12 cells (n = 15 rats). For both protocols, BDIX rats were sacrificed at day 30 after injection. The preliminary protocol showed that intraportal injection of 10(6) DHD/K12 cells was associated with bilobar micrometastases of 0.8 mm mean diameter at day 30. The main protocol assessed that direct injection of 0.5 × 10(6) under the liver median lobe capsule and intraportal injection of 10(6) DHD/K12 cells were associated at day 30 with a single macroscopic metastasis confined to a liver lobe and bilobar micrometastases, without peritoneal carcinomatosis or lung metastasis. Thus we have developed a new experimental model of bilobar colorectal LM including both macro- and microscopic colorectal LMs, which mimics the human situation and which will be useful in preclinical studies.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Experimental model (right) and corresponding clinical situation (left): single macroscopic liver metastasis (black colour) and multiple diffuse micrometastases (grey colour).
Figure 2
Figure 2
Experimental workflow.
Figure 3
Figure 3
Optical microscopy of micrometastasis obtained 30 days after intraportal injection of 1 × 106 DHD/K12 cells (stain: haematoxylin–eosin–saffran).
Figure 4
Figure 4
Micrometastases diameter obtained 30 days after intraportal injection of 1 × 106 DHD/K12 cells, 2 × 106 DHD/K12 cells or 3 × 106 DHD/K12 cells and macrometastases diameter obtained 30 days after subcapsular injection of 0.5 × 106 DHD/K12 cells, 1 × 106 DHD/K12 cells or 1.5 × 106 DHD/K12 cells under the liver capsule of the median lobe.
Figure 5
Figure 5
Macrometastasis obtained 30 days after subcapsular injection of 0.5 × 106 DHD/K12 cells under the liver capsule of the median lobe. (a): Full liver specimen; (b): optical microscopy of macrometastasis (stain: haematoxylin–eosin–saffran).

References

    1. Alves A, Vibert E, Trajcevski S, et al. Adjuvant interleukin-12 gene therapy for the management of colorectal liver metastases. Cancer Gene Ther. 2004;11:782–789. - PubMed
    1. Anisimov VN, Ukraintseva SV, Yashin AI. Cancer in rodents: does it tell us about cancer in humans? Nat. Rev. Cancer. 2005;5:807–819. - PubMed
    1. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature. 1998;392:245–252. - PubMed
    1. Bresalier RS, Hujanen ES, Raper SE, et al. An animal model for colon cancer metastasis: establishment and characterization of murine cell lines with enhanced liver-metastasizing ability. Cancer Res. 1987;47:1398–1406. - PubMed
    1. Cai SR, Garbow JR, Culverhouse R, et al. A mouse model for developing treatment for secondary liver tumors. Int. J. Oncol. 2005;27:113–120. - PubMed

Publication types